A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG(1) Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies

B.C. Kuenen, P.O. Witteveen, R. Ruijter, G. Giaccone, A. Dontabhaktuni, F. Fox, T. Katz, H. Youssoufian, J.M. Zhu, E.K. Rowinsky, E.E. Voest

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1915-1923
JournalClinical Cancer Research
Issue number6
Publication statusPublished - 2010

Cite this